Akari Therapeutics, Plc

AKTXNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

140.03B

on 2026-06-30, from 15.97B on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

S-3 of 2025-07-29. Not read yet. S-3 ↗

13 of its filings are not read yet.

Warrants

6.93M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

2.9 quarters

$7.7M on 2026-06-30 ÷ $2.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-12-16	Registered direct offering	10,043,774	$0.3883	$3.9M	424B5 ↗
2025-12-16	Registered direct offering	not read	not read	$5.0M	8-K ↗

Also on file: a 1-for-40 reverse split, 2026-03-17 8-K ↗